Identification of Dual Cyclooxygenase–Eicosanoid Oxidoreductase Inhibitors: NSAIDs That Inhibit PG-LX Reductase/LTB4 Dehydrogenase
- 9 November 2001
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 288 (4), 868-874
- https://doi.org/10.1006/bbrc.2001.5841
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Lipid mediator class switching during acute inflammation: signals in resolutionNature Immunology, 2001
- Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathwaysJCI Insight, 2001
- Series Introduction: COX in a crystal ball: current status and future promise of prostaglandin researchJCI Insight, 2001
- Oxidoreductases in Lipoxin A4 Metabolic InactivationJournal of Biological Chemistry, 2000
- Formation of Endogenous “Antiinflammatory” Lipid Mediators by Transcellular BiosynthesisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Identification of dithiolethione-inducible gene-1 as a leukotriene B4 12-hydroxydehydrogenase: implications for chemoprevention.Carcinogenesis: Integrative Cancer Research, 1998
- Purification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lungBiochemical Journal, 1998
- cDNA Cloning, Expression, and Mutagenesis Study of Leukotriene B4 12-HydroxydehydrogenasePublished by Elsevier BV ,1996
- 15-Hydroxyprostaglandin dehydrogenaseJournal of Lipid Mediators and Cell Signalling, 1995
- 15-Hydroxyprostaglandin dehydrogenase. A reviewProstaglandins, 1976